Analyzing patient data to understand TMS effects on depression and anxiety
Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes
This study looks at real patient data to see how different factors affect the success of TMS therapy for people dealing with depression and anxiety.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 156000 (estimated) |
| Ages | 5 Years to 120 Years |
| Sex | All |
| Sponsor | Neuronetics Academic / other |
| Locations | 1 site (Malvern, Pennsylvania) |
| Trial ID | NCT06917339 on ClinicalTrials.gov |
What this trial studies
This observational study utilizes real-world data from the TrakStar database to analyze how various patient characteristics, symptoms, and TMS protocol parameters influence clinical outcomes in patients receiving NeuroStar TMS therapy. By examining data from patients treated since November 2008, the study aims to identify patterns and correlations that could enhance treatment efficacy. The focus is on conditions such as depression, obsessive-compulsive disorder, and anxiety depression, providing insights into the effectiveness of TMS in these populations.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have received TMS therapy for depression or anxiety-related conditions since November 2008.
Not a fit: Patients with incomplete treatment information or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from depression and anxiety disorders.
How similar studies have performed: Other studies utilizing real-world data to analyze TMS outcomes have shown promising results, indicating that this approach is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date of November 01, 2008 or later. Exclusion Criteria: • Incomplete information on treatment parameters
Where this trial is running
Malvern, Pennsylvania
- Neuronetics — Malvern, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Neha Goyal
- Email: neha.goyal@neurostar.com
- Phone: 763-528-1599
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.